Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Potential of Metabolic Imaging.
Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India.
Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability.
Zinc sulphate: A reasonable choice for depression management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial.
HLA-DRB1*15 influences the development of brain tissue damage in early PPMS.
Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey.
Alexithymia in Neurological Disease: A Review.
Diazepam Inhibits Proliferation of Lymph Node Cells Isolated from Rats with Experimental Autoimmune Encephalomyelitis.
The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.
First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis.
Relationship between Damage to the Cerebellar Peduncles and Clinical Disability in Multiple Sclerosis.
Relationship between subjective and objective cognitive performance in multiple sclerosis.
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination.
Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.
Prediction of disease severity in neuromyelitis optica by the levels of IL-6 produced during remission phase.
Oct4-induced oligodendrocyte progenitor cells enhance functional recovery in spinal cord injury model.
Glutamate, Glutamate Receptors, and Downstream Signaling Pathways.
Depression and sleep disturbances in patients with multiple sclerosis and correlation with associated fatigue.
Neurofascin antibodies in inflammatory neuropathy: How many needles make a haystack?
Induced brain plasticity after a facilitation programme for autobiographical memory in multiple sclerosis: a preliminary study.
Secondary progressive multiple sclerosis: a shared therapeutic decision.
Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis.
Somatosensory temporal discrimination threshold is impaired in patients with multiple sclerosis.
Combined exercise training reduces fatigue and modulates the cytokine profile of T-cells from multiple sclerosis patients in response to neuromediators.
Pages
« first
‹ previous
…
422
423
424
425
426
427
428
429
430
…
next ›
last »